GET THE APP

Role of inflammatory biomarkers in chronic obstructive pulmonary disease
..

Pulmonary & Respiratory Medicine

ISSN: 2161-105X

Open Access

Role of inflammatory biomarkers in chronic obstructive pulmonary disease


4th International Conference and Exhibition on Lung & Respiratory Care

August 01-02, 2016 Manchester, UK

Ola Alkady

Sohag University, Egypt

Posters & Accepted Abstracts: J Pulm Respir Med

Abstract :

Purpose: Chronic obstructive pulmonary disease (COPD) is a multicomponent disease. There is a need for biological markers for better evaluation of patients with COPD. We tested the hypothesis that elevated levels of inflammatory biomarkers fibrinogen, C-reactive protein (CRP) and leukocyte count (WBC) in individuals with stable COPD are associated with an increased risk of exacerbation. Patients and methods: Ninety-eight COPD patients diagnosed and classified as COPD and 30 age and gender matched healthy subjects with normal pulmonary function were observed. Patient follow-up was performed to evaluate the strength of the associations between inflammatory biomarker levels and future outcome. Results: Inflammatory biomarkers increase with exacerbation compared to the remission state, mean WBC, CRP and fibrinogen at 12.212├?┬?109/L, 39.462 mg/L and 5.09 g/L in exacerbation respectively compared to 7.877├?┬?109/L, 4.142 mg/L and 2.299 g/L in remission with P values <0.001, <0.001 and <0.004, respectively. Statistically significant correlation was noticed between the levels of fibrinogen and the % predicted FEV1 (r=0.209, P=0.038) however CRP and WBC did not correlate with % predicted FEV1 (r=_0.031, P=0.765) for CRP, and that for WBC (r=0.125, P=0.221). Conclusion: Elevated levels of CRP, fibrinogen and leukocyte count in individuals with COPD were associated with increased exacerbation risk. Clinical Implications: Inflammatory biomarkers hold promise for improving the understanding of the complex mechanisms propagating COPD exacerbation. Fibrinogen in particular has emerged as a potentially useful biomarker and requires further investigation.

Biography :

Ola Alkady completed education at Sohag University in Egypt. Currently researching on Chronic obstructive pulmonary disease (COPD) is a multicomponent disease.

Email: olaalkady2001@yahoo.com

50+ Million Readerbase

Recommended Conferences

Journal Highlights

Google Scholar citation report
Citations: 1513

Pulmonary & Respiratory Medicine received 1513 citations as per Google Scholar report

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward